Market Overview

Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Receptos, Inc. Stockholders

Share:
NEW YORK--(BUSINESS WIRE)--

Kirby McInerney LLP is investigating potential claims against the Board of Directors of Receptos, Inc. ("Receptos" or the "Company") (NASDAQ: RCPT) concerning the proposed acquisition of the Company by Celgene Corporation. Pursuant to the terms of the definitive agreement, Receptos stockholders will receive $232.00 in cash for each share of Receptos common stock they own, in a transaction valued at approximately $7.2 billion.

The investigation concerns whether the Receptos Board of Directors violated its fiduciary duties by agreeing to the proposed transaction and whether the proposed consideration adequately values the Company's common stock.

If you are a Receptos stockholder and wish to obtain additional information, please contact J. Brandon Walker, Esq. by email at bwalker@kmllp.com, or telephone at (212) 699-1145 or toll free at (888) 529-4787, or by filling out this contact form. There is no cost or obligation to you.

Kirby McInerney LLP is a New York-based law firm concentrating in securities, whistleblower, antitrust and consumer litigation. For additional information, please go to www.kmllp.com.

Kirby McInerney LLP
J. Brandon Walker, Esq., (212) 699-1145
toll free: (888) 529-4787
bwalker@kmllp.com

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com